Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Antibiotics (Basel, Switzerland)|September 23, 2022
Homocysteine and Inflammatory Cytokines in the Clinical Assessment of Infection in Venous Leg UlcersIlaria Cavallo, Ilaria Lesnoni La Parola, Francesca Sivori, et al.Viruses|August 23, 2020
Oral Infection by Mucosal and Cutaneous Human Papillomaviruses in the Men Who Have Sex with Men from the OHMAR StudyTarik Gheit, Francesca Rollo, Rosario N Brancaccio, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2021
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive FindingArturo Ciccullo, Vanni Borghi, Andrea Giacomelli, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 21, 2024
SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIVAlessandra Vergori, Alessandro Cozzi-Lepri, Alessandro Tavelli, et al.Journal of Clinical Medicine|November 28, 2019
Impact of Antiretroviral Therapy on the Risk of Recurrence in HIV-1 Infected Patients with Kaposi Sarcoma: A Multicenter Cohort ExperienceManuela Colafigli, Arturo Ciccullo, Alberto Borghetti, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line TherapyMassimiliano Fabbiani, Alberto Borghetti, Nicola Squillace, et al.The Journal of Antimicrobial Chemotherapy|September 16, 2021
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced diseaseYagai Bouba, Daniele Armenia, Federica Forbici, et al.Journal of Experimental & Clinical Cancer Research : CR|January 17, 2015
Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi's sarcoma and non-Kaposi's casesPaola Cordiali-Fei, Elisabetta Trento, Marta Giovanetti, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 9, 2018
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatmentDaniele Armenia, Mauro Zaccarelli, Vanni Borghi, et al.Journal of Global Antimicrobial Resistance|July 6, 2022
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practiceDaniele Armenia, Federica Forbici, Ada Bertoli, et al.Pageof 11